Dr. Herminia Palacio is president and CEO of the Guttmacher Institute, which seeks to expand reproductive rights and Robin Marty is director of operations at West Alabama Women's Center, which had to cease offering abortions nearly 12 months ago.
Mayo Clinic’s Chief Information Officer Cris Ross, who’s been leading innovation projects for over 30 years, says “perhaps” we should be worried about ChatGPT.
Dr. Vivian Lee joins hosts Mark Masselli and Margaret Flinter to explain why we need health care providers and health systems to step up to do more about the undeniable risks from climate change.
The Centers for Disease Control and Prevention just updated its ventilation guidance on helping prevent indoor transmission of the virus that causes COVID. It includes a recommendation to get at least five air changes per hour of clean air in occupied spaces.
Miriam Delphin-Rittmon, Ph.D., serves as Assistant Secretary for Mental Health and Substance Use for the U.S. Department of Health and Human Services.
Philip Zelikow, co-author of the new book "Lessons from the COVID War,” has an important finding as the U.S. still grapples with the tough questions from the pandemic.
Republicans in the U.S. House passed a deal that lifts the debt ceiling along with spending cuts aimed at the nation’s health care safety net.
Anti-tobacco advocates just had another big win: New York, California, and several other states reached a settlement worth nearly $500 million against e-cigarette maker Juul Labs.
A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling.
Join Mark Masselli and Margaret Flinter as they talk with three leading health care journalists: Amy Goldstein with The Washington Post; Joyce Frieden with MedPage Today; and Jessica Bartlett with The Boston Globe.
Dr. Jesse Ehrenfeld, the first openly gay person to be elected as president of the American Medical Association, joins hosts Mark Masselli and Margaret Flinter to discuss potential cuts to federal health care and the need for more diversity in the doctors’ ranks.
Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic.
Hosts Mark Masselli and Margaret Flinter have Dr. Margaret Hamburg unpack the report and ask this former U.S. Food & Drug Administration commissioner what bumps are ahead for what they call a “roadmap to value.”
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.